BG
CDMO

Bollard Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bollard Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-249
Closed -$3K – 675
2023
Q2 		$3K Buy
+249
New +$4.24K ﹤0.01% 498

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bollard Group's CDMO Position: Q3 2023 in Review

Bollard Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2023, closing a stake of 249 shares — an estimated $3K sold.

Bollard Group first reported a position in CDMO in Q2 2023 and held it in 1 quarter. The position peaked at $3K in Q2 2023. 170 funds tracked by Wall St. Rank hold CDMO as of Q3 2023.

  • Bollard Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bollard Group sold 249 Avid Bioservices, Inc. Common Stock shares in Q3 2023, an estimated $3K.
  • Bollard Group first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Bollard Group's Avid Bioservices, Inc. Common Stock position peaked at $3K in Q2 2023.
  • 170 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2023.

Based on Bollard Group's 13F filing for Q3 2023, filed 14 Nov 2023.